Table of Contents Author Guidelines Submit a Manuscript
Malaria Research and Treatment
Volume 2015 (2015), Article ID 878132, 8 pages
http://dx.doi.org/10.1155/2015/878132
Clinical Study

Efficacy and Safety of Artesunate-Amodiaquine versus Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium falciparum Malaria in Sentinel Sites across Côte d’Ivoire

1Faculty of Pharmacy, Department of Parasitology and Mycology, Félix Houphouët-Boigny University, BPV 34, Abidjan, Côte d’Ivoire
2Malaria Research and Control Centre, National Institute of Public Health, BPV 47, Abidjan, Côte d’Ivoire
3Parasitology and Mycology Laboratory of Diagnosis and Research Centre on AIDS and Opportunistic Diseases, 01 BPV 13, Abidjan, Côte d’Ivoire

Received 6 January 2015; Revised 22 May 2015; Accepted 5 July 2015

Academic Editor: Sanjeev Krishna

Copyright © 2015 William Yavo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, World Malaria Report, World Health Organization, Geneva, Switzerland, 2013.
  2. Ministère de la Santé et de l'Hygiène Publique. PNLP, Directives de prise en charge du paludisme, PNLP, Abidjan, Côte d'Ivoire, 2008.
  3. B. K. Brice, Y. William, O. Lacina et al., “In vitro susceptibility of Plasmodium falciparum isolates from Abidjan, Côte d'Ivoire, to artemisinin, chloroquine, dihydroartemisinin and pyronaridine,” Tanzania Journal of Health Research, vol. 12, supplement 1, pp. 73–79, 2010. View at Google Scholar · View at Scopus
  4. World Health Organization, Antimalarial Drug Combination Therapy: Report of a Technical Consultation, World Health Organization, Geneva, Switzerland, 2001.
  5. Ministère de la santé et de l’hygiène publique, “Arrêté N°024/CAB/MSHP du 02 janvier 2007 portant institution d’un schéma thérapeutique pour le traitement du paludisme en Côte d’Ivoire,” Abidjan: Journal officiel, 2007.
  6. A. M. Dondorp, R. M. Fairhurst, L. Slutsker et al., “The threat of artemisinin-resistant malaria,” The New England Journal of Medicine, vol. 365, no. 12, pp. 1073–1075, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Noedl, Y. Se, K. Schaecher, B. L. Smith, D. Socheat, and M. M. Fukuda, “Evidence of artemisinin-resistant malaria in western Cambodia,” The New England Journal of Medicine, vol. 359, no. 24, pp. 2619–2620, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. R. M. Fairhurst, G. M. L. Nayyar, J. G. Breman et al., “Artemisinin-resistant malaria: research challenges, opportunities, and public health implications,” The American Journal of Tropical Medicine and Hygiene, vol. 87, no. 2, pp. 231–241, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. C. V. Plowe, “The evolution of drug-resistant malaria,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 103, supplement 1, pp. S11–S14, 2009. View at Google Scholar
  10. World Health Organization, Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria, World Health Organization, Geneva, Switzerland, 2003.
  11. B. Faye, T. Kuété, C. P. Kiki-Barro et al., “Multicentre study evaluating the non-inferiority of the new paediatric formulation of artesunate/amodiaquine versus artemether/lumefantrine for the management of uncomplicated Plasmodium falciparum malaria in children in Cameroon, Ivory Coast and Senegal,” Malaria Journal, vol. 11, article 433, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Menan, O. Faye, A. Same-Ekobo et al., “Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine—trimethoprim versus artemether-Lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal,” Malaria Journal, vol. 10, article 185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Yavo, B. Faye, T. Kuete et al., “Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa,” Malaria Journal, vol. 10, article 198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. C. I. Fanello, C. Karema, W. van Doren, C. van Overmeir, D. Ngamije, and U. D'Alessandro, “A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 101, no. 4, pp. 344–350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. R. E. L. Paul, I. Hackford, A. Brockman et al., “Transmission intensity and Plasmodium falciparum diversity on the northwestern border of Thailand,” American Journal of Tropical Medicine and Hygiene, vol. 58, no. 2, pp. 195–203, 1998. View at Google Scholar · View at Scopus
  16. I. Soulama, I. Nébié, A. Ouédraogo et al., “Plasmodium falciparum genotypes diversity in symptomatic malaria of children living in an urban and a rural setting in Burkina Faso,” Malaria Journal, vol. 8, article 135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. G. O. Adjei, J. A. L. Kurtzhals, O. P. Rodrigues et al., “Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up,” Malaria Journal, vol. 7, article 127, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Bukirwa, A. Yeka, M. R. Kamya et al., “Artemisinine combination therapies for treatment of uncomplicated malaria in Uganda,” PLoS Clinical Trials, vol. 1, no. 1, article e7, 2006. View at Publisher · View at Google Scholar
  19. J.-P. Guthmann, S. Cohuet, C. Rigutto et al., “High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola,” American Journal of Tropical Medicine and Hygiene, vol. 75, no. 1, pp. 143–145, 2006. View at Google Scholar · View at Scopus
  20. A. Mårtensson, J. Strömberg, C. Sisowath et al., “Efficacy of artesunate plus amodiaquine versus that of artemether- lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania,” Clinical Infectious Diseases, vol. 41, no. 8, pp. 1079–1086, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Piola, C. Fogg, F. Bajunirwe et al., “Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial,” The Lancet, vol. 365, no. 9469, pp. 1467–1473, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Schramm, P. Valeh, E. Baudin et al., “Efficacy of artesunate-amodiaquine and Artemether-Lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial,” Malaria Journal, vol. 12, article 251, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. M. van Vugt, S. Looareesuwan, P. Wilairatana et al., “Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 5, pp. 545–548, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Kobbe, P. Klein, S. Adjei et al., “A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children,” Malaria Journal, vol. 7, article 261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Ratcliff, H. Siswantoro, E. Kenangalem et al., “Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison,” The Lancet, vol. 369, no. 9563, pp. 757–765, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Zongo, G. Dorsey, N. Rouamba et al., “Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial,” The Lancet, vol. 369, no. 9560, pp. 491–498, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Zongo, G. Dorsey, N. Rouamba et al., “Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso,” Clinical Infectious Diseases, vol. 45, no. 11, pp. 1453–1461, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Van Den Broek, C. Kitz, S. Al Attas, F. Libama, M. Balasegaram, and J.-P. Guthmann, “Efficacy of three artemisinin combination therapies for the treatmentof uncomplicated Plasmodium falciparum malaria in the Republic of Congo,” Malaria Journal, vol. 5, article 113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. G. O. Gbotosho, A. Sowunmi, T. M. Okuboyejo et al., “Therapeutic efficacy and effects of artemether-lumefantrine and artesunate-amodiaquine coformulated or copackaged on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in Southwest Nigeria,” American Journal of Tropical Medicine and Hygiene, vol. 84, no. 5, pp. 813–819, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. P. P. G. Kremsner and P. S. Krishna, “Antimalarial combinations,” The Lancet, vol. 364, no. 9430, pp. 285–294, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Sowunmi, T. Balogun, G. O. Gbotosho, C. T. Happi, A. A. Adedeji, and F. A. Fehintola, “Activities of amodiaquine, artesunate, and artesunate-amodiaquine against asexual- and sexual-stage parasites in falciparum malaria in children,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 5, pp. 1694–1699, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Sowunmi, S. T. Balogun, G. O. Gbotosho, and C. T. Happi, “Effects of amodiaquine, artesunate, and artesunate-amodiaquine on Plasmodium falciparum malaria-associated anaemia in children,” Acta Tropica, vol. 109, no. 1, pp. 55–60, 2009. View at Publisher · View at Google Scholar · View at Scopus